You searched for "scarring"
Positives and negatives of managing diplopia in adults with prisms
This study recruited consecutive patients prescribed prisms during a two-year period, within set criteria of a deviation up to 30 prism diopters, good fusion, willingness to wear prisms and no previous unsuccessful use of prisms. The majority of cases had...Ultra-widefield imaging in glaucoma: Documenting hypotony-related choroidal effusions after microshunt surgery
Ultra-widefield (UWF) imaging provides extended visualisation of the posterior segment beyond the traditional 30–50° field of view. It captures a broad view of the posterior pole and periphery in a single, quick, non-mydriatic acquisition. While its role in diabetic retinopathy...The Royal College of Surgeons of Edinburgh: Foundations in Surgical Leadership June 26
The Royal College of Surgeons of Edinburgh Foundations in Surgical LeadershipThe Royal College of Surgeons of Edinburgh: Foundations in Surgical Leadership April 26
Royal College of Surgeons Edinburgh Foundations in Surgical LeadershipOphtherminator 3 - Rise of the Machines
“Bring back life form, priority one, all other priorities are rescinded.” Film buffs will spot this as a chilling quote spoken by Ash (Ian Holm) from the classic sci-fi horror movie Alien (1979). Ash (spoiler alert) is a Hyperdyne Systems...Astigmatism correction in cataract surgery: Why are we still hesitating?
Toric spectacle lenses were first described in 1847 by George Biddell Airy, and their adoption was, presumably, gradual at that time. Today, correction of astigmatism with glasses is routine. In a recent survey, 87.2% of spectacle prescriptions contained at least...£5 million award for world-leading research facilities within new eye health centre
The Sir Jules Thorn Charitable Trust has awarded £5 million to UCL in partnership with Moorfields Eye Charity and Moorfields Eye Hospital to support Oriel – a centre for advancing eye health, opening in 2027.
Aflibercept, bevacizumab or ranibizumab for diabetic macular oedema
Macular oedema (MO) is a leading cause of visual impairment in patients with diabetic retinopathy. Whilst laser photocoagulation therapy has been the proven treatment for decades, studies over the last five years have also established a role for anti-VEGF agents...
